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We isolated a novel gram-positive bacterium, Brevibacillus texasporus, that produces an antibiotic, BT. BT is
a group of related peptides that are produced by B. texasporus cells in response to nutrient limitation. We
report here purification and determination of the structure of the most abundant BT isomer, BT1583.
Amino acid composition and tandem mass spectrometry experiments yielded a partial BT1583 structure.
The presence of ornithine and D-form residues in the partial BT1583 structure indicated that the peptide
is synthesized by a nonribosomal peptide synthetase (NRPS). The BT NRPS operon was rapidly and
accurately identified by using a novel in silico NRPS operon hunting strategy that involved direct shotgun
genomic sequencing rather than the unreliable cosmid library hybridization scheme. Sequence analysis of
the BT NRPS operon indicated that it encodes a colinear modular NRPS with a strict correlation between
the NRPS modules and the amino acid residues in the peptide. The colinear nature of the BT NRPS
enabled us to utilize the genomic information to refine the BT1583 peptide sequence to Me2-4-methyl-4-
[(E)-2-butenyl]-4,N-methyl-threonine-L-dO-I-V-V-dK-V-dL-K-dY-L-V-CH2OH. In addition, we report the
discovery of novel NRPS codons (sets of the substrate specificity-conferring residues in NRPS modules)
for valine, lysine, ornithine, and tyrosine.
Novel antibiotics are needed to combat infections caused by
bacteria that are resistant to conventional antibiotics. It is well
known that microbes produce a huge variety of antibiotics to wage
chemical warfare against competing microbes. We screened soil
microorganisms for strains that produce novel antibiotics. Bacillus
sp. strain E58 ( ATCC PTA-5854) was isolated for its ability to
produce the antibiotic BT against Staphylococcus aureus strains
that cause life-threatening infections (Jiang and Munoz-Romero,
unpublished results). This strain was named Brevibacillus texas-
porus based on its relatedness to Brevibacillus laterosporus.
Many peptide antibiotics of microbial origin (mostly from
actinomycetes, bacilli, and fungi) are synthesized by nonribo-
somal peptide synthetases (NRPS), and they contain unusual
amino acids. NRPS usually have a colinear modular architec-
ture (15). The N-terminal to C-terminal order and the speci-
ficities of the individual modules correspond to the sequential
order and identities of the amino acid residues in the peptide
product. Each NRPS module recognizes a specific amino acid
and catalyzes stepwise condensation to form a growing peptide
chain. The identity of the amino acid recognized by a particular
module can be predicted by comparisons to other modules
having known specificities (3). Such strict correlation made it
possible to identify genes encoding the NRPS enzymes for a
number of microbial nonribosomal peptides with known struc-
tures, as demonstrated by identification of the mycobactin bio-
synthesis operon in the genome of Mycobacterium tuberculosis
(18). Conversely, an NRPS operon may be a source of infor-
mation that allows researchers to determine certain structural
details of the peptide product. In this study, we show that
identification of the BT NRPS operon resulted in critical re-
finements of the BT1583 peptide structure.
The modules of an NRPS are composed of smaller units or
“domains,” each of which has a specific role in the recognition,
activation, modification, or joining of amino acid precursors to
form the peptide product. One type of domain, the adenylation
domain (A-domain), is responsible for selectively recognizing
and activating the amino acid that is to be incorporated by a
particular module of the NRPS. Through analysis of the sub-
strate-binding pocket of the A-domain of the PheA subunit of
the gramicidin S NRPS in combination with sequence compar-
ison with other A-domains, it was possible to define 10 residues
that are the main determinants of the substrate specificity for
an A-domain (4, 21). The 10 residues are considered an NRPS
“codon.” The NRPS codon collection is still growing as new
NRPS codons continue to be discovered. In this paper, we
describe novel NRPS codons for valine, lysine, ornithine, and
tyrosine. The amino acid activation step is ATP dependent and
involves the transient formation of an aminoacyl adenylate.
The reaction consumes one ATP and generates one PPi. An
ATP-PPi exchange assay has been developed to measure the
substrate specificity for an A-domain (10, 14).
The activated amino acid is covalently attached to the pep-
tide synthetase through another type of domain, the thiolation
domain (T-domain), which is generally located adjacent to the
A-domain. The T-domain is posttranslationally modified by
covalent attachment of a phosphopantetheinyl prosthetic arm
to a conserved serine residue. The activated amino acid sub-
strates are tethered to the NRPS via a thioester bond to the
phosphopantetheinyl prosthetic arm of the corresponding T-
domains. Amino acids joined to successive units of the NRPS are
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subsequently covalently linked together by the formation of
amide bonds catalyzed by another type of domain, the conden-
sation domain (C-domain). NRPS modules can also occasionally
contain additional functional domains that carry out auxiliary
reactions, and the most common of these is epimerization of
an amino acid substrate from the L form to the D form. This
reaction is catalyzed by a domain referred to as an epimer-
ization domain (E-domain), which is generally located ad-
jacent to the T-domain of a given NRPS module. Thus, a
typical NRPS module has the following domain organiza-
tion: C-A-T-(E).
Product assembly by NRPS involves three distinct phases,
namely, chain initiation, chain elongation, and chain termina-
tion (8). Peptide chain initiation is carried out by specialized
modules termed “starter modules” that comprises an A-do-
main and a T-domain. Elongation modules have, in addition, a
C-domain that is located upstream of the A-domain. It has
been experimentally demonstrated that such elongation do-
mains cannot initiate peptide bond formation due to interfer-
ence by the C-domain (12). All the growing peptide intermedi-
ates are covalently tethered to the NRPS during translocations as
an elongating series of acyl-S-enzyme intermediates. To release
the mature peptide product from the NRPS, the terminal acyl-S-
enzyme bond must be broken. This process is the chain termina-
tion step and is usually catalyzed by a C-terminal thioesterase
domain (TE-domain). Thioesterase-mediated release of the ma-
ture peptide from the NRPS enzyme involves transient formation
of an acyl-O-TE intermediate that is then hydrolyzed or hydro-
lyzed and concomitantly cyclized to release the mature peptide
(7). An alternative termination scheme involves reduction of the
tethered C-terminal residue by a reductase domain (R-domain)
that resides in the last NRPS module, resulting in release of a
peptide with an alcoholic C-terminal residue (5, 9). Such a reduc-
tase-mediated termination/C-terminal modification occurs in BT
biosynthesis and contributes to superprotease resistance of the
BT peptides.
MATERIALS AND METHODS
Partial purification of BT. B. texasporus E58 cells were grown in 1 liter of LB
in an air shaker at 37°C for 3 days. The culture was spun in a clinical centrifuge
at 3,000 rpm for 15 min. The supernatant was collected, and 500 g of ammonium
sulfate was added and dissolved. The sample was spun in the clinical centrifuge
at 3,000  g for 15 min. The pellet was dissolved in 200 ml of distilled water. The
solution was then boiled for 15 min and then cooled on ice. The sample was
filtered with a 0.2-m filter (Nalgene). The filtrate was mixed with 0.2 liter of
chloroform at room temperature for 20 min with a stir bar. The mixture was
separated into two phases by centrifugation in the clinical centrifuge at 3,000 rpm
for 15 min. The organic phase was collected and dried in a vacuum evaporator.
C18 reverse-phase HPLC. The dried chloroform extract was dissolved in 2 ml
of sterile distilled water. The solution was fractionated on a C18 reverse-phase
high-performance liquid chromatography (HPLC) column by using a gradient
from 30% solution B to 55% solution B (solution B was 0.075% trifluoroacetic
acid in acetonitrile, and solution A was 0.1% trifluoroacetic acid in water). The
resulting fractions were dried, dissolved in sterile distilled water, and analyzed
for anti-S. aureus activity with a Kirby-Bauer assay. The peak fraction (fraction
33) was subjected to amino acid composition, mass spectrometry (MS), tandem
mass spectrometry, and chirality analyses.
Detection of D-form amino acid residues. The chiral analysis of amino acid
residues in BT was performed by Commonwealth Biotechnologies, Inc., Richmond,
VA. BT was subjected to hydrolysis in 6 N HCl in vacuo for 18 h at 110°C. The
amino acids were derivatized to 9-fluorenylmethoxy carbonyl amino acids and
separated by HPLC. The elution profile of each amino acid was then determined
on a chiral column. For both types of chromatography columns, peaks were
identified by comparison with appropriate standards.
Genomic DNA preparation. Log-phase E58 cells were harvested from an LB
culture and lysed with lysis buffer (10 mM Tris [pH 8.0], 100 mM EDTA, 0.5%
sodium dodecyl sulfate). RNase A was added to digest contaminating RNA.
Genomic DNA was extracted with phenol-chloroform and then precipitated with
ethanol. Dried DNA was resuspended in Tris-EDTA, and an aliquot was elec-
trophoresed in a 0.5% agarose gel for quality control.
Library construction and genome sequencing. E58 genomic library construc-
tion, shotgun sequencing, and assembly were performed by Agencourt Bio-
sciences Corporation (Beverly, MA). Briefly, the whole genome library was
constructed with an average insert length of around 5 kb. A total of 10,000 clones
were subjected to automated DNA sequencing from both ends of the insert;
16,901 successfully sequenced reads were obtained.
Nucleotide sequences and data analysis. All BLAST analyses with the E58
genome were performed by using the WU BLAST software package (version 2.0)
installed on a local computer (W. Gish, 1996 to 2003; http://BLAST.wustl.edu).
Amino acid sequence homology searches were performed by using the BLAST
server at the National Center for Biotechnology Information (Bethesda, Md.)
and a nonredundant protein sequence database with default parameter values
(1). Amino acid sequence alignment was performed by using the CLUSTALW
program (2) running at the NPS@ web server at the Institute of Biology and
Chemistry of Proteins (Lyon, France).
Cloning, overexpression, and purification of His10-tagged BT A-domain pro-
teins. DNA fragments encoding the A-domains of BT NRPS modules 8, 5, 7, 4, and
2 (Bt8A, Bt5A, Bt7A, Bt4A, and Bt2A) were PCR amplified, and the PCR products
were inserted into His10-tagged recombinant protein expression vector pET16b
(Novagen). The A-domain borders were determined as described by Konz et al. (10).
The expression constructs were transformed into the Escherichia coli BL21-AI strain
(Invitrogen). Transformants were grown in L broth at 37°C to anA600 of 0.6 and then
induced with 1 mM IPTG (isopropyl--D-thiogalactopyranoside) plus 0.2% L-arab-
inose. The cells were allowed to grow for two additional hours at 30°C before they
were harvested. The His10-tagged recombinant proteins were purified by using
TALON metal affinity resins (BD Biosciences) under conditions recommended in
the manual.
ATP-PPi exchange assay. ATP-PPi exchange assays were performed to deter-
mine the substrate specificity of an A-domain. ATP-PPi exchanges were assayed
as previously described (20).
MIC determination assays. S. aureus was grown to the mid-log phase in LB at
37°C, diluted 500-fold with fresh LB, and dispensed into 96-well microtiter
plates. Different concentrations of peptides were added, and the microtiter plates
were incubated at 37°C with shaking. The MIC was the lowest peptide concen-
tration that produced a clear well. All experiments were performed in triplicate,
and highly consistent MICs were obtained.
Nucleotide sequence accession number. The DNA sequence of the BT NRPS
operon has been deposited in the GenBank database under accession no.
AY953371.
RESULTS
Identification of the BT peptide. Bacterial strain E58 was
isolated from soil in an effort to identify soil microorganisms
that produce novel antibiotics for use against S. aureus. E58
was found to be closely related to B. laterosporus based on 16S
rRNA gene sequence homology (98.5% identity) (Jiang and
Ballard, unpublished results). E58 was named B. texasporus
and deposited in the ATCC (catalog number ATCC PTA-
5854). The antibiotic produced by E58 was named BT, and its
activity could be detected in the supernatant of a liquid LB E58
culture. The antibiotic activity was precipitated by ammonium
sulfate, which suggested that the antibiotic is a protein or
peptide (data not shown). The activity was further extracted
with chloroform, and the chloroform extract was analyzed by
Tricine-sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. The two halves of a gel with identical lanes in each
half were either stained for proteins and peptides or overlaid
with agar containing the BT-sensitive bacterium Bacillus cereus
to test for antibiotic activity (Fig. 1A). The following three
species were visible after staining: the bromophenol blue dye
that originated from the gel loading buffer, an unknown pep-
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tide with a molecular mass of 1.4 kDa, and a third species
with antibiotic activity. The third species produced a1.5-kDa
band at low concentrations (clearly visible on the original gel)
and was later shown to be made up of a group of related
peptides (see below). The apparent mass increased with concen-
tration, suggesting that the peptides aggregate at higher concen-
trations. An antibiotic activity was associated with the peptides at
higher concentrations, and we therefore concluded that the pep-
FIG. 1. Purification of peptide BT. (A) Tricine gel separation of BT and the associated antibiotic activity. Chloroform-treated extracted
peptides were separated on a precast 16.5% Tricine gel (purchase from Bio-Rad). One gel was stained with Coomassie blue to show peptide bands.
Another gel was overlaid with agar containing B. cereus. Clear zones in the bacterial lawn correspond to the species that collapses into a single band
at a molecular weight of 1,500. The following molecular mass markers were used: triose phosphate isomerase (26.6 kDa), myoglobin (17.0 kDa),
alpha-lactalbumin (14.4 kDa), aprotinin (6.5 kDa), insulin b chain (oxidized) (3.5 kDa), and bacitracin (1.4 kDa). SDS, sodium dodecyl sulfate.
(B) Mass spectrometry of chloroform-extracted BT. Chloroform-extracted BT was treated with sodium by addition of sodium chloride and then
subjected to mass spectrometry analysis. Five sodium-containing BT isomers (BT1555, BT1571, BT1583, BT1599, and BT1613) were detected and
labeled. (C) Mass spectrometry of purified BT1583. Fraction 33 from C18 reverse-phase HPLC was subjected to mass spectrometry analysis. Only
protonated, sodium-containing, and potassium-containing BT1583 were detected.
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tides likely conferred the BT antibiotic activity. The peptides were
referred as the BT peptides. The BT peptides apparently were not
toxic to B. cereus at lower concentrations in this assay. Since the
smallest detectable BT band was at1.5 kDa, we concluded that
the BT peptides contained approximately 13 residues.
The chloroform-extracted BT was subject to a mass spec-
trometry assay. A group of peptides were detected in the range
between 1,550 and 1,650 Da (Fig. 1B). The main species had a
molecular weight of 1,583, and it was designated BT1583. The
other peptides were later shown to be isomers of BT1583.
Determination of partial BT sequence. The chloroform-ex-
tracted BT was purified further by C18 reverse-phase HPLC
(see Materials and Methods for details). BT1583 was purified
to homogeneity in fraction 33 by C18 HPLC (Fig. 1C). An
amino acid composition analysis of BT1583 (fraction 33)
showed that BT1583 contained Tyr, Lys, Leu, Ile, Val, and Orn
residues (Table 1). BT1583 was refractory to N-terminal se-
quencing and resistant to degradation by aminopeptidase M,
suggesting that there was a nonstandard N-terminal residue.
BT1583 was also resistant to cleavage by carboxypeptidase Y,
suggesting that there was a nonstandard C-terminal amino acid.
Carboxyl-terminal sequencing was, therefore, not attempted.
Tandem mass spectrometry (MS-MS) was then used to se-
quence the BT1583 peptide. MS-MS data were obtained for
BT1583, and they are shown in Fig. 2A and Table 2. The
MS-MS data indicated that BT1583 contained 13 amino acid
residues that correlated well with the amino acid composition.
As expected, the molecular masses of residues 1 and 13 did not
correspond to the molecular masses of any standard amino
acids. The last residue had a molecular mass of 103 Da, which
appeared to be compatible with valinol (a valine whose C termi-
nus is reduced from a carboxylic acid to an alcohol). The presence
of a C-terminal valinol was further confirmed by the presence of
a reductase domain in the 13th valine-specific module of the BT
NRPS (see below). The identity of the N-terminal residue was
more difficult to determine. Nonetheless, an N-terminal residue
with a molecular mass of 198 seemed to be compatible with the
N,N-methylated form of 4-methyl-4-[(E)-2-butenyl]-4,N-methyl-
threonine (Bmt) (16, 17).
The presence of ornithine and possibly Bmt in BT1583 in-
dicated that BT1583 could not be synthesized by ribosomes.
The presence of D amino acids would strengthen this idea. We
chose to assess the chiral properties of two of the most abun-
dant residues in BT1583, Val and Leu. Chiral analyses re-
vealed uniform L-Val residues, but there were both L- and
D-Leu residues at a ratio of 2:1.
The biochemical and structural analyses described above
provided a partial BT1583 peptide sequence (Table 2 and
Fig. 2B). The structures of the N- and C-terminal residues
were not fully determined. Isoleucine and leucine could not be
distinguished. The position of the D form of Leu was not
specified. Chiral properties of other residues in the peptide
were not determined.
FIG. 2. (A) BT1583 tandem mass spectrometry data. (B) Partial BT1583 sequence structure deduced from amino acid composition and MS-MS
experiments. See Tables 1 and 2.
TABLE 1. Amino acid composition of purified BT1583 peptide
Amino acid Amt(nmol)
Molar ratios
normalized to: No. of residues
per peptide
Tyr Ile
Tyrosine 1.75 1.00 1.16 1
Valine 4.58 2.62 3.05 3
Isoleucine 1.50 0.86 1.00 1
Leucine 5.32 3.04 3.54 3
Lysine 3.57 2.04 2.38 2
Ornithine 1.2 0.69 0.80 1
Total for derivatizable
residues
10.25 11.93 11
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Shotgun sequencing of the E58 genome. To better under-
stand the structure and biosynthesis of the BT1583 peptide, we
decided to identify the gene or operon that is responsible for
BT biosynthesis. As mentioned above, BT1583 is likely to be
synthesized by the NRPS in vivo (13). Most of the NRPS genes
are colinear, reflecting a strict correlation between NRPS mod-
ules and the amino acid residues in the peptide product. If the
BT NRPS operon is colinear, it should encode 13 modules
corresponding to the 13 amino acid residues in the BT1583
peptide. Assuming that each module is encoded by an average
3.5-kb DNA fragment, a DNA fragment that is 46 kb long
would be needed to accommodate the BT NRPS operon. The
traditional method used to identify an NRPS operon involves
probing a cosmid library with a generic probe. Since an imper-
fect generic probe may miss the target gene and there are
usually multiple NRPS operons in a bacterial genome, re-
searchers often waste time chasing the wrong NRPS operons.
To avoid this pitfall, we adopted a genomic approach that
provided an unbiased in silico assessment of all NRPS operons
in a genome to allow direct comparisons of the NRPS operons
and therefore rational candidate operon selection. This novel
approach resulted in rapid and accurate identification of the
BT NRPS operon.
The E58 genome was estimated to be 5 Mb long. An E58
genomic library was constructed with an average insert size of
5 kb. The whole genome was sequenced for twofold coverage.
After sequence assembly, the E58 genome was represented by
1,919 contigs whose sizes ranged from 700 bp to 22.6 kb and
932 singlets. Such coverage allowed 99.995% of the genome to
be represented by clones. Also, the average length of the gap
between two neighboring contigs was as short as 250 bp, so that
supercontigs could be constructed (see below). Moreover, su-
percontigs at this resolution should contain sufficient informa-
tion to allow accurate in silico NRPS operon identification.
In silico identification of the BT NRPS operon. A three-step
procedure was used to select the candidate BT NRPS operon.
First, all contigs and singlets were searched for sequences
encoding NRPS modules. Since E58 is related to Bacillus sub-
tilis, the putative peptide synthetase PPS1 sequence from B.
subtilis was chosen as the query sequence for BLAST analysis
with a database containing all assembled E58 contigs. A total
of 128 contigs showed translated amino acid sequence similar-
ity to PPS1, with P values ranging from 0 to 1.
Second, supercontigs were constructed from the 128 contigs.
Two sequencing reads from the ends of the same insert formed
a mate pair. A supercontig is a collection of contigs joined by
mate pairs that reside in different contigs. Identification of
mate pairs allowed neighboring contigs to be ordered and
orientated to form a supercontig (Fig. 3A). Thirty-one super-
contigs were successfully constructed to represent the whole
E58 NRPS operon portfolio.
Third, the candidate BT NRPS operon was selected from
the E58 NRPS operon portfolio. The 31 supercontigs were
examined for the possibility that they harbored the BT NRPS
operon, and supercontig 3 (whose genetic features based on
finished sequence are shown in Fig. 3B and C) was chosen as
the candidate based on the following findings.
(i) Supercontig 3 was big enough to potentially contain a
DNA sequence encoding 13 NRPS modules.
(ii) The available information regarding the A-domian sub-
strate specificities of supercontig 3 was compatible with the
partial BT1583 sequence. Complete sets of substrate specific-
ity-conferring amino acid residues could be identified for 11
modules (all modules except modules 2 and 13 due to an
incomplete DNA sequence). Although not all specificity pre-
dictions could be made, good correlations between predicted
NRPS amino acid substrates and the partial BT1583 sequence
were established. Specifically, module 4 was predicted to in-
corporate Ile, and modules 9 and 12 were predicted to incor-
porate Leu (Table 3; see below for details). The partial BT1583
sequence had Leu or Ile at positions 4, 9, and 12. Phylogenetic
analysis of the substrate-conferring amino acids of the 11 mod-
ules showed that modules expected to incorporate the same or
very similar amino acids did group together (Fig. 3D). For
example, modules 5, 6, and 8, which were all predicted to
incorporate Val, formed a cluster, and modules 7, 10, and 3,
which were predicted to incorporate similar cationic amino
acids (Lys and Orn), formed another cluster.
(iii) The E-domain positions in the NRPS encoded by su-
percontig 3 showed compatibility with the partial BT1583 pep-
tide structure. Four E-domains were found in modules 3, 7, 9,
and 11 (Fig. 3C). Their positions were consistent with the
BT1583 chiral properties of all L-Val residues mentioned
above and a ratio of L-Leu to D-Leu of 2:1.
Supercontig 3 was therefore identified as the candidate locus
for the BT NRPS operon. Primer extension and genome walking
TABLE 2. Tandem mass spectrometry of BT1583
M/H b
series M
Possible amino
acid residue
M/H y
series M
Possible amino
acid residue
Compiled
(N to C)
198.10 (CH3)2-Bmt (?) (CH3)2-Bmt (?)
311.16 113.06 L/I 1386.73 113.12 L/I L/I
425.21 114.05 O 1273.61 114.04 O O
538.28 113.07 L/I 1159.57 113.05 L/I L/I
637.32 99.04 V 1046.52 198.08 VV V
V
864.42 227.10 VK 848.44 128.07 K K
963.46 99.04 V 720.37 99.04 V V
1076.52 113.06 L/I 621.33 L/I
1204.58 128.06 K K
1367.65 163.07 Y Y
1480.81 113.16 L/I L/I
1583.87 103.06 Val-CH2OH Val-CH2OH
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FIG. 3. BT NRPS operon. (A) Construction of a supercontig from two contigs linked by a mate pair. Contig 1 and contig 2 share a mate pair
from a clone. The contigs are ordered and arranged to form a supercontig, which contains the sequences of contig 1 and contig 2, which are
separated by an unsequenced gap region. (B) Region sequenced in this work and location of 10 ORFs found in the region. Six ORFs (btA through
btF) encode the BT NRPS subunits. (C) Domain organization of the BT NRPS subunits. The predicted amino acid substrate specificity of each
module is indicated in each A-domain. (D) Phylogenetic tree for a multiple-sequence alignment of all 13 binding pocket constituents described
in Table 3. The putative specificity was assigned using the partial BT1583 sequence. The binding pockets of A-domains that supposedly activate
the same or similar substrate cluster together.
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were performed to obtain a high-quality sequence of the locus.
These efforts resulted in a 50,674-bp contig covering the putative
BT NRPS operon (GenBank accession no. AY953371).
Putative BT NRPS subunits. Ten open reading frames (ORFs)
were identified in the sequenced region through translation
analysis and BLAST searches (2) (Fig. 3B). The middle six
ORFs (designated btA through btF) were predicted to encode
six subunits of the BT NRPS (BtA through BtF), and their
coordinates are shown in Table 4. Sequence analysis of the
putative subunits confirmed the modular structure of a typical
colinear NRPS (Fig. 3C). The modules, each containing an
A-domain and a T-domain, are linked by a C-domain. The
loading module BtA has an A-domain followed by a T-domain.
There are two noticeable overall features of the putative BT
NRPS subunits. First, four of the six subunits exhibit a two-
module structure. Second, all auxiliary E-domains are present
at the end rather than in the middle of the putative NRPS
subunits. Sequence alignments of conserved domains are
shown in Fig. 4.
Reductase domain in module 13. A domain consisting of
about 500 amino acids was identified at the C terminus of BtF
or module 13. BLAST analysis showed that this domain has
high levels of similarity with several NADPH-dependent re-
ductases from other NRPSs and polyketide synthetases. An
alignment of this domain with the reductase domains of MxcG
of Stigmatella aurantiaca and Lys2 of Saccharomyces cerevisiae
is shown in Fig. 4E. A similar reductase domain has also been
identified in the gramicidin A NRPS (9). All three reductases
have been experimentally demonstrated to reduce their sub-
strates to corresponding aldehydes in an NADPH-dependent
reaction (5, 9, 19). For myxochelin A and gramicidin A, the
aldehydes are further reduced to alcohols. The exact mecha-
nism for the second reduction step has not been identified.
Either the reductases themselves or other proteins carry out
the second reduction step or the second reduction step is
spontaneous. The MS-MS experiment suggested that the C-
terminal residue of BT1583 might be valinol (Fig. 2B). The
A-domain specificity prediction for the last putative BT NRPS
module and the presence of a reductase domain in the module
confirmed this suggestion.
btG encodes an ABC transporter. btG is an ORF that is imme-
diately downstream of btF, and it is transcribed in the same di-
rection as other BT ORFs. The initiation codon, ATG, is located
61 bp downstream of the btF stop codon. The translated amino
acid sequence exhibited high levels of similarity to members of the
ATP-binding cassette (ABC) transporter superfamily (data not
shown). ABC transporter ORFs are found in typical NRPS oper-
ons. They have been proposed to provide the host with resistance
to the peptide antibiotic product by pumping the peptide out of
the cells. The exact role of the putative BtG ABC transporter
needs to be established.
BT1583 peptide sequence refinement. The substrate speci-
ficity-conferring residues (21) were extracted from all 13 A-do-
mains and were compared to the collection of amino acid-
binding pocket constituents in the public NRPS codon database
(raynam.chm.jhu.edu/nrps/index.html) (3). Substrate speci-
ficity predictions were made based on the sequence align-
ments, and they are shown in Table 3. The amino acid-binding
pocket constituents of the first module showed a perfect match
with an NRPS codon for threonine/dehydrothreonine, and it
was predicted that module 1 incorporates a threonine deriva-
tive. N,N-methylated Bmt was proposed to be the N-terminal
amino acid residue according to the MS-MS data (Fig. 2B and
Table 2). Although the two proposals do not completely agree
TABLE 3. Predicted BT NRPS module substrate specificities and refinement of the BT1583 peptide structure
Module
Amino acid at PheA residuea: Predicted
substrate
specificity
Partial BT1583
sequence
Refined BT1583
sequence235 236 239 278 299 301 322 330 331 517
1 D F W N I G M V H K Thr/Dht (CH3)2-Bmt?
b (CH3)2-Bmt?
2 D G F L L G G V F K Ile/Leu Leu/Ile Leuc
3 D S G P S G A V D K Ornb Orn
4 D G F F L G V V Y K Ileb Leu/Ile Ile
5 D G F F V G G V F K Ile/Leu/Val Valb Val
6 D G F F V G G V F K Ile/Leu/Val Valb Val
7 D A G P S G A V D K Lysb Lys
8 D G F F V G G V F K Ile/Leu/Val Valb Val
9 D A W F L G N V V K Leub Leu/Ile Leu
10 D A G P S G A V G K Lysb Lys
11 D A A A V V G V A K Phe/Trp/Tyr Tyrb Tyr
12 D A W F L G N V W K Leub Leu/Ile Leu
13 D G F F A G G V F K Ile/Leu/Val Val-CH2OH
b Val-CH2OH
a The residues were numbered according to the corresponding residues of PheA (4).
b The information was used for BT1583 peptide sequence refinement.
c The Leu at this position was deduced from the fact that the only Ile had been assigned to position 4.
TABLE 4. ORFs of the BT NRPS operon
ORF Start(nucleotide)
End
(nucleotide)
Length
(bp)
Gene product
Length
(amino
acids)
Mol wt
(103) Homology
btA 2861 4786 1,926 641 72.87 NRPS
btB 4789 12381 7,593 2,530 288.99 NRPS
btC 12410 26263 13,854 4,617 526.68 NRPS
btD 26293 33918 7,626 2,541 289.31 NRPS
btE 33948 41528 7,581 2,526 288.45 NRPS
btF 41556 49031 7,476 2,491 284.46 NRPS
btG 49092 49814 723 240 26.95 ABC
transporter
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with each other, both indicate that a threonine derivative is the
N-terminal amino acid residue.
As mentioned above, three unambiguous specificity assign-
ments could be made for module 4 (Ile), module 9 (Leu), and
module 12 (Leu) according to the NRPS codon database.
These assignments were compatible with the partial BT1583
sequence; accordingly, positions 4, 9, and 12 of the BT1583
peptide were refined to Ile, Leu, and Leu, respectively. Since
the only Ile of the BT1583 peptide had been assigned to po-
sition 4, the remaining Leu was assigned to position 2. The
A-domain specificity of module 2 was therefore deduced to be
Leu. These assignments, in conjunction with the E-domain
position information, allowed us to refine the BT1583 peptide
sequence to (CH3)2-Bmt-Leu-dOrn-Ile-Val-Val-dLys-Val-dLeu-
Lys-dTyr-Leu-Val-CH2OH.
Novel NRPS codons in BT biosynthesis. As mentioned
above, the amino acid-binding pocket constituents of modules
5, 6, and 8 are identical. They differ from those of module 13
FIG. 4. Conserved motifs and alignments of the adenylation, condensation, thiolation, epimerization, and reductase domains from the BT
NRPS modules. Conserved motifs were identified as described by Marahiel (13). Consensus sequences are indicated under each alignment.
Residues that are the same as consensus residues are indicated by a black background. All 12 C-domains were aligned, and asterisks indicate the
start C-domains that are known to be less conserved.
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by only one residue. No good matches were found for these
sets of amino acid-binding pocket constituents in the NRPS
codon database. However, they showed similarities to cer-
tain Ile, Leu, or Val NRPS codons in the database. Since the
partial BT1583 peptide sequence had Val residues at posi-
tions 5, 6, 8, and 13, modules 5, 6, 8, and 13 were deduced
to incorporate Val. The amino acid-binding pocket constit-
uents of modules 5, 6, 8, and 13 represent potential novel
NRPS codons for Val.
The amino acid-binding pocket constituents of modules 7
and 10 are identical, and they differ from those of module 3 by
only one residue. No match was found for these sets of amino
acid-binding pocket constituents in the NRPS codon database.
Since the partial BT1583 peptide sequence had Lys residues at
positions 7 and 10, the specificities of these modules were
deduced to be Lys. Likewise, the partial BT1583 peptide se-
quence had an Orn residue (whose structure is very similar to
that of Lys) at position 3, and the specificity of module 3 was
therefore deduced to be Orn. The amino acid-binding pocket
constituents of modules 7 and 10 represent potentially the first
NRPS codon for Lys, while those of module 3 represent a
potential novel NRPS codon for Orn.
The specificity prediction for module 11 was quite ambigu-
ous according the NRPS codon database. No good match was
found for this set of amino acid-binding pocket constituents in
the NRPS codon database. However, module 11 showed sim-
ilarities to certain Phe, Trp, or Tyr NRPS codons in the data-
base (data not shown). Since the partial BT1583 peptide
sequence had Tyr residues at position 11, the A-domain spec-
ificity of module 11 was therefore deduced to be Tyr. The
FIG. 4—Continued.
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amino acid-binding pocket constituents of module 11 represent
a potential novel NRPS codon for Tyr.
Experimental testing of the novel NRPS codons. Since BT
biosynthesis involves novel NRPS codons, experimental estab-
lishment of the novel codons (especially the novel valine and
lysine codons) is critical for verifying the identity of the BT
NRPS operon. In addition, since the placement of Ile at posi-
tion 4 in BT1583 affects the placement of three Leu residues,
the module 4 codon also needs to be tested. The A-domain
specificity of module 2 was deduced to be Leu, and it also
needs to be tested.
Since a purified recombinant A-domain of an NRPS module
can selectively and efficiently activate the cognate amino acid
substrate of the NRPS module in an ATP-PPi exchange assay
(10, 14), ATP-PPi exchange assays were used to experimentally
establish NRPS module specificities and novel NRPS codons.
Recombinant A-domains of modules 8, 5, 7, 4, and 2 of the BT
NRPS were produced and purified as described in Methods
and Materials. Almost completely soluble recombinant A-do-
main proteins were obtained. A-domain specificities were de-
termined in ATP-PPi exchange and amino acid Km assays (see
Methods and Materials). All 20 proteinogenic amino acids and
L-Orn were tested for each A-domain protein, and the back-
ground noise in the experiments was usually less than 1%.
The module 8 A-domain protein was shown to activate L-Val
(100%), and there was minor activation of L-Lys (10%) and
L-Ile (4%). The apparent Km was determined to be 2.75 mM
for L-Val. These results confirmed the novel valine NRPS
codon. Similarly, the module 5 A-domain protein was found to
activate L-Val (100%), L-Ile (23%), and L-Leu (17%). The
apparent Km values were determined to be 1.11 mM for L-Val
and 2.78 mM for L-Ile, clearly showing that L-Val is the pre-
ferred substrate for module 5.
L-Lys was the only amino acid that activated by the module
7 A-domain protein. The apparent Km was determined to be
1.12 mM. These results established the first Lys NRPS codon.
The module 4 A-domain protein was shown to selectively
activate L-Ile (100%), and there was minor activation of L-Val
(9%) and L-Leu (7%). The apparent Km for L-Ile was 0.5 mM.
The module 2 A-domain protein was found to be quite
ambiguous. It activated L-Leu (98%) and L-Met (100%) with
nearly equal efficiency, and there was significant activation
of L-Val (67%) and minor activation of L-Ile (19%) and
L-Phe (3.5%).
In general, all purified A-domain proteins were found to
selectively activate predicted amino acid substrates in the
ATP-PPi exchange assays. These results experimentally con-
firmed the identity of the BT NRPS operon.
Verification of the identity of the BT NRPS operon. The results
described above allowed us to propose a degenerate formula for
the isomers of BT1583 (Table 5). Based on the relative substrate
selectivity of each module, the BT isomers likely to be produced
by B. texasporus in significant amounts were predicted, and most
FIG. 4—Continued.
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of the predicted BT isomers have been detected by MS-MS (such
as BT1555, BT1571, BT1583, BT1599, and BT1613 in Fig. 1B).
Synthetic peptides. To further verify the BT peptide se-
quence as well as the identity of the BT NRPS operon, syn-
thetic peptide P81 (Fig. 5) was made by Biomer Technology
(Concord, CA) and tested to determine its properties. Since
Bmt is not commercially available, we were not able to synthe-
size a peptide according to the refined BT1583 sequence, and
we used octanic acid-modified threonine to synthesize the li-
popeptide P81 to mimic BT1583. P81 showed antibiotic activ-
ities and pronase resistance similar to that of BT1583. These
results support the refined BT1583 peptide sequence and the
identity of the BT NRPS operon.
To investigate the significance of the C-terminal alcoholic
modification, an amide form of P81 (P59) was synthesized. P59
displayed antibiotic activity but no pronase resistance. These
results indicated that the C-terminal alcoholic modification
plays a key role in conferring protease resistance to P81 and
likely to BT1583 as well.
Since the codon for the first BT NRPS module matches
known Thr NRPS codons perfectly, the possibility of an active
BT isomer with an unmodified Thr at position 1 needed to be
investigated. An N-terminally unmodified form of P59 (P58)
was therefore synthesized, and P58 displayed poor antibiotic
activity. This result confirmed that a derivative of (rather than
unmodified) Thr had to be at position 1 to confer full BT
antibiotic activity.
We noticed that the L- and D-form residues alternate in
the middle of BT1583 with the exception of position 5 (Val).
Since alternating chirality is a key structural feature for the
peptide antibiotic gramicidin A, we investigated whether we
missed the coding sequence of an E-domain for module 5. A
D/L alternating version of P59 (P80) was synthesized. P80
displayed no antibiotic activity. The results described above
confirmed not only the BT1583 peptide structure (with the
exception of the N-terminal residue) but also the identity of
the BT NRPS operon.
DISCUSSION
In silico NRPS operon identification. Identification and iso-
lation of an NRPS operon are essential to studies of a peptide
antibiotic. However, identification of a specific NRPS operon
remains a challenging task. Identification of an NRPS operon
traditionally starts with identification of clones in a genomic
BAC or cosmid library by hybridization with DNA probes from
known NRPS genes or gene fragments amplified by PCR of
genomic DNA using degenerate primers. Because the amino
acid sequences of NRPS domains are usually quite similar,
such approaches can be successful. However, because probes
or primers are often imperfect, some NRPS operons can be
missed. Moreover, microbes often contain multiple NRPS
operons, so that the probes or primers may reveal some
NRPS operons but not the operon sought. This often results
in ill-fated efforts devoted to an incorrect gene (6).
We reasoned that the initial NRPS gene identification could
be made more rationale if all NRPS operons in the genome
were compared at the same time so that the best fit could be
found. Such a comparison would require a draft of the genome.
Fortunately, sequencing costs have decreased significantly so
that academic labs can sequence microbial genomes. As we
show here, twofold coverage is sufficient for accurate NRPS
operon identification. In the actual BT NRPS operon selec-
tion, the following two sets of information were generated and
compared to find the best candidate: the NRPS module clus-
tering pattern according to similarities of the substrate-binding
pocket constituents (Fig. 3D) and position information, such as
the positions of D-form residues. In our opinion, the module
clustering technique is especially powerful for establishing the
candidacy of an operon that involves unknown NRPS codons
(e.g., in the case of modules 5, 6, and 8 of the BT NRPS
operon). The in silico strategy is particularly useful for NRPS
operon identification in organisms (such as B. texasporus) that
have a large number of NRPS operons in their genomes. Al-
though the use of shotgun genomic sequencing to find NRPS
genes for known peptides has been reported previously (11),
using shotgun genomic sequencing to refine the structure of a
peptide was not attempted before this study.
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FIG. 5. Synthetic BT variants. (A) Structures of synthetic BT variants.
(B) Properties of the BT variants. The antibiotic activities were measured
by determining the MICs for S. aureus as described in Materials and
Methods. For pronase resistance assays, the peptides were incubated with
pronase overnight at 37°C in phosphate-buffered saline, and the residual
antibiotic activities against S. aureus were determined.
TABLE 5. Degenerate formula for the BT isomers
Amino acid at positiona:
1 2 3 4 5 6 7 8 9 10 11 12 13
Me2-Bmt L dO I V V dK V dL K dY L V-CH2OH
M V I
V L
I
F
a The numbers indicate the amino acid residues from the N terminus to the C
terminus. Entries indicate possible amino acid residues at each position.
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